Related Experiment Video

Updated: May 12, 2026

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α
11:27

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α

Published on: November 2, 2018

The pivotal role of IKKα in the development of spontaneous lung squamous cell carcinomas

Zuoxiang Xiao1, Qun Jiang, Jami Willette-Brown

  • 1Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, Frederick, MD 21701, USA.

Cancer Cell
|April 20, 2013
PubMed

Insights

Kinase-dead IKKα knockin mice spontaneously develop lung squamous cell carcinomas (SCCs) due to IKKα downregulation and inflammation. Bone marrow-derived macrophages promote SCC development, offering potential therapeutic targets.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Inflammation is linked to various cancers, including lung squamous cell carcinoma (SCC).
  • The role of Inhibitor of κB kinase α (IKKα) in lung SCC development is not fully understood.
  • Specific molecular markers like p63, Trim29, and keratin 5 (K5) are associated with human lung SCCs.

Purpose of the Study:

  • To investigate the role of IKKα in lung SCC development using a kinase-dead IKKα knockin mouse model.
  • To identify the cellular and molecular mechanisms driving SCC formation in this model.
  • To explore potential therapeutic strategies for lung SCC.

Main Methods:

  • Generation of kinase-dead IKKα knockin mice.
  • Analysis of lung tissue for SCC development, inflammation, and marker expression (p63, Trim29, K5).
  • Experimental interventions including reintroducing K5.IKKα, macrophage depletion, and bone marrow transplantation.

Main Results:

  • Kinase-dead IKKα knockin mice developed spontaneous lung SCCs associated with IKKα downregulation and pulmonary inflammation.
  • IKKα reduction upregulated p63, Trim29, and K5, mirroring human lung SCC markers.
  • Bone marrow-derived IKKα mutant macrophages were identified as key promoters of SCC progression.

Conclusions:

  • A novel mouse model for lung SCC has been established, closely resembling human disease.
  • IKKα downregulation and inflammation, driven by bone marrow-derived macrophages, are critical in lung SCC pathogenesis.
  • The findings identify potential therapeutic targets for lung SCC treatment.

More Related Videos

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification10:21

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification

Published on: September 20, 2024

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...